Envy Medical launches new Lumixyl Brightening System for treating hyperpigmentation

Envy Medical, Inc., introduces the new Lumixyl™ Brightening System, a revolutionary multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids. This professional skincare system introduction builds on the success of the Lumixyl Topical Brightening Creme introduced in 2009.

"The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare," explains Dr. Basil Hantash, MD, PhD, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology.

An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin.

"Physicians and the public at large have been calling for a viable alternative to prescription hydroquinone therapies," commented Envy Medical CEO, Curtis A. Cluff.  "We are very pleased to be able to answer that call with a system that provides visible brightening with a safe and non-irritating formula."

The Lumixyl Topical Brightening System builds on the four products including Active-Prep Cleanser, the Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotion, and Moisture-Lock Sunscreen SPF 30.  The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.  

Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians.  The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto Canada-based BASIS Medical Technologies. 

SOURCE Envy Medical, Inc.